We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

8 hedge funds and large institutions have $1.75M invested in Innovator IBD ETF Leaders ETF in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

20% less funds holding

Funds holding: 108 (-2)

24% less capital invested

Capital invested by funds: $2.29M → $1.75M (-$538K)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$777K +$160K +7,497 +22%
Citadel Advisors
2
Citadel Advisors
Florida
$385K +$24.5K +1,145 +6%
Jane Street
3
Jane Street
New York
$211K -$131K -6,106 -35%
LPL Financial
4
LPL Financial
California
$187K -$183K -8,572 -46%
Osaic Holdings
5
Osaic Holdings
Arizona
$73K +$83.8K +3,917 New
UBS Group
6
UBS Group
Switzerland
$58K +$34.7K +1,623 +107%
ASN
7
Advisory Services Network
Georgia
$37K
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$19K +$7.49K +350 +54%

LDRS Hedge Fund Activity: Q1 2020 in Review

8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2020, worth a combined $1.75M — down 24% from $2.29M a quarter earlier.

Fund positioning in LDRS was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $160K. The largest seller was LPL Financial, cutting an estimated $183K.

  • 8 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2020, down from 10 in Q4 2019.
  • Funds reported $1.75M of Innovator IBD ETF Leaders ETF stock for Q1 2020, down 24% quarter-over-quarter.
  • 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q1 2020 and 1 closed out, a net change of 0 holders.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $160K added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q1 2020 was LPL Financial, an estimated $183K sold.

Based on aggregated 13F filings for Q1 2020.